Galvin Gaustad & Stein LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Galvin Gaustad & Stein LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 417 shares of the medical equipment provider’s stock, valued at approximately $218,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in ISRG. Armistice Capital LLC increased its stake in shares of Intuitive Surgical by 65.7% during the 2nd quarter. Armistice Capital LLC now owns 71,227 shares of the medical equipment provider’s stock valued at $31,685,000 after acquiring an additional 28,250 shares during the last quarter. AQR Capital Management LLC grew its holdings in Intuitive Surgical by 12.6% in the second quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock valued at $18,958,000 after purchasing an additional 4,775 shares during the period. APG Asset Management N.V. increased its position in Intuitive Surgical by 3.4% during the second quarter. APG Asset Management N.V. now owns 234,279 shares of the medical equipment provider’s stock worth $97,242,000 after purchasing an additional 7,648 shares during the last quarter. DE Burlo Group Inc. purchased a new position in Intuitive Surgical during the second quarter worth approximately $4,982,000. Finally, Daymark Wealth Partners LLC boosted its holdings in shares of Intuitive Surgical by 3.6% in the 2nd quarter. Daymark Wealth Partners LLC now owns 7,003 shares of the medical equipment provider’s stock valued at $3,115,000 after purchasing an additional 246 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 42,475 shares of company stock worth $22,070,807 in the last 90 days. 0.90% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on ISRG shares. BTIG Research upped their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Royal Bank of Canada raised their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Leerink Partners boosted their target price on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Finally, Truist Financial raised their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 18th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $608.66 on Friday. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $616.00. The firm has a market cap of $216.79 billion, a price-to-earnings ratio of 97.86, a PEG ratio of 5.13 and a beta of 1.39. The stock’s 50-day simple moving average is $544.61 and its 200-day simple moving average is $502.64.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.